3 ms·
Vaccines are a tool, not a silver bullet. We would have realized this earlier
- nradov 5y agoIt's disappointing that the official US NIH COVID-19 treatment guidelines still don't recommend fluvoxamine. The evidence seems pretty solid now, and the risks of taking it for just a few days are very low for most patients https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/fluvoxamine/ https://www.covid19treatmentguidelines.nih.gov/therapies/imm... Anecdotal reports indicate that US physicians are already frequently prescribing it off label with good results.